Intelligence Β· Clinical Pipeline
Phase I Pipeline Programs
First-in-human and early clinical safety studies in Phase I.
- Programs
- 4,713
Quick answer
NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.
Top sponsors
- BRIGHT MINDS BIOSCIENCES 327 programs
- Takeda 276 programs
- Anaxis Pharma 204 programs
- Chinese Academy of 190 programs
- United Therapeutics Europe 184 programs
- Teva Pharma 154 programs
- First People's Hospital 149 programs
- Regeneron UK 126 programs
- Boehringer Ingelheim 94 programs
- Sunshine Guojian Pharmaceutical 85 programs
- Lakefront Biotherapeutics NV 62 programs
- HOFFMANN-LA ROCHE 58 programs
-
olaparib
United Therapeutics Europe Ltd
Advanced Cancer
1 trial -
omacetaxine mepesuccinate
Teva Pharma GmbH
Hematologic Malignancies
1 trial -
ombrabulin (AVE8062)
Sanofi Pasteur
Neoplasms, Malignant
1 trial -
oncolytic virus (OVV-01) injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Neoplasms
1 trial -
oral naltrexone
BRIGHT MINDS BIOSCIENCES INC.
Opioid Dependence
1 trial -
oral palifosfamide tris
Alaunos Therapeutics
Advanced Cancer
1 trial -
oral treprostinil
United Therapeutics Europe Ltd
Raynaud's Phenomenon
1 trial -
oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
6 trials -
pCAR-19B cells
Chongqing Precision Biotech Co., Ltd
Acute Lymphoblastic Leukemia, in Relapse
1 trial -
pTVG-HP with rhGM-CSF
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
paclitaxel cationic liposome for injection
CSPC Baike (Shandong) Biopharmaceutical Co.,
Colorectal Liver Metastases
1 trial -
palifosfamide-tris
Alaunos Therapeutics
Malignancy
1 trial -
palifosfamide-tris
Alaunos Therapeutics
Advanced Solid Tumors
1 trial -
pandemic influenza vaccine (H5N1 strain NIBRG-14)
Sinovac Research and Development Co.,
Pandemic Influenza Vaccine
1 trial -
patisiran
Alnylam Netherlands B.V.
Polyneuropathies
1 trial -
patisiran (ALN-TTR02)
Alnylam Netherlands B.V.
Transthyretin (TTR)-Mediated Amyloidosis
1 trial -
pd-1 and DC-NK cells
The First People's Hospital of Lianyungang
Solid Tumor
1 trial -
pd-1 and dc-cik cells
The First People's Hospital of Lianyungang
Solid Tumor
1 trial -
peficitinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy Volunteers
1 trial -
placebo
Lakefront Biotherapeutics NV
Healthy
1 trial -
placebo
Innovent Biologics (Suzhou) Co.
Healthy
1 trial -
placebo control
Takeda
Hemophilia
1 trial -
pomalidomide
Celgene Europe Limited
Multiple Myeloma in Relapse
1 trial -
pravastatin
Teva Pharma GmbH
Healthy
2 trials -
pravastatin sodium
Teva Pharma GmbH
Healthy
1 trial -
prophylactic 4SCAR19 cells
The First People's Hospital of Lianyungang
B Acute Lymphoblastic Leukemia
1 trial -
pyroglutamate rongliflozin capsules
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Type 2 Diabetes
1 trial -
pyroglutamate rongliflozin capsules
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Diabetes Mellitus, Type 2
1 trial -
questionnaires
Cardiff Oncology
Anxiety
1 trial -
quitSTART Mobile Application
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Vaping
1 trial -
rAAVrh74.MHCK7.DYSF.DV
Sarepta Therapeutics
Dysferlinopathy
1 trial -
rHuPH20
HALOZYME THERAPEUTICS, INC.
Healthy Volunteers
1 trial -
rHuPH20
HALOZYME THERAPEUTICS, INC.
Risk Factors for or a Diagnosis of Osteoporosis
1 trial -
rQNestin
Candel Therapeutics
Malignant Glioma of Brain
1 trial -
rSIFN-co
Sichuan Provincial People's Hospital
Carcinoma, Non-Small-Cell Lung
1 trial -
radioactive substance
BRIGHT MINDS BIOSCIENCES INC.
Amphetamine-Related Disorders
1 trial -
randomized, double-blinded, placebo-controlled
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prevention of COVID-19 Caused by SARS-CoV-2
1 trial -
recombinant adenovirus containing the ornithine transcarbamylase gene
Ultragenyx UK Limited
Ornithine Transcarbamylase Deficiency Disease
1 trial -
recombinant human thrombopoietin injection
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Liver Disease Chronic
1 trial -
removal of omentum
United Therapeutics Europe Ltd
Diabetes Mellitus Type 2
1 trial -
rhASA - Dose Level 1
Takeda
Metachromatic Leukodystrophy (MLD)
1 trial -
rhPTH(1-84)
Takeda
Healthy Volunteers
1 trial -
riliprubart
Vera Therapeutics
Autoimmune haemolytic anaemia
1 trial -
rilonacept (IL-1 Trap)
Regeneron UK Limited
Systemic Juvenile Idiopathic Arthritis
1 trial -
routine HIV testing
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial -
sD-NP-GT8 DNA
INOVIO PHARMACEUTICALS, INC.
HIV Infections
1 trial -
sabirnetug (ACU193)
Acumen Pharmaceuticals
Alzheimer Disease
1 trial -
salvianolic acid A
The First People's Hospital of Lianyungang
Healthy
1 trial
Frequently asked questions
How many Phase I pipeline programs are in the directory?
4,713 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.
Data attribution: Data sources Β· All pipeline programs